Last updated: February 20, 2026
What Are the Scope and Claims of Patent AR036852?
Patent AR036852 pertains to a pharmaceutical invention filed or granted within Argentina. The scope primarily covers specific formulations, methods, or compounds related to a particular therapeutic application. An analysis of its claims reveals the boundaries of patent protection.
Claims Overview
- Claim 1: Defines the core invention as a chemical compound/formulation with a specified structure, concentration, or combination. It sets the broadest protection, covering all embodiments encompassed by the structural or functional features.
- Dependent Claims: Detail specific variations, such as dosage forms, delivery methods, or auxiliary components, providing narrower protection.
- Method Claims: Cover specific therapeutic or manufacturing processes related to the primary compound or formulation.
Key Details from the Claims
| Claim Type |
Content Summary |
Scope Summary |
| Independent |
Covers the main compound/formulation with broad parameters. |
Encompasses all variants fitting the structure. |
| Dependent |
Encompasses specific formulations, such as sustained-release forms, or specific excipients. |
Limits scope to particular embodiments. |
| Method |
Describes associated processes, such as synthesis or administration. |
Provides protection for specific manufacturing or use methods. |
Note: The scope remains as a function of how broad or narrow the claims are drafted. Specific phrasing determines the extent of protection and overlap with prior art.
Patent Landscape for Pharmaceuticals in Argentina
Patent Filing Trends
- Argentina's pharmaceutical patent filings peaked in the early 2010s, stabilized since 2014, with approximately 150-200 patent applications annually.
- The landscape shows a high concentration of innovation in formulations for chronic disease treatments.
Patent Laws and Policy Environment
- Argentina's patent system is governed by Law 24,481, aligning with WTO TRIPS Agreement standards.
- The patent term is 20 years from the filing date.
- Patents for pharmaceuticals require compliance with both patentability criteria and local regulatory approval.
Major Patent Holders and Key Competitors
- Top patent filers include multinational pharmaceutical companies and local biotech firms.
- Domestic filings often focus on local diseases and formulations adapted to regional needs.
- Notable competitors hold patents in anti-infectives, oncology drugs, and generics.
Patent Clusters and Overlap
- Clusters exist around anti-inflammatory and antiviral agents.
- Overlaps with adjacent patents are common in compounds' structural claims.
- Patent thickets may impede generic entry shortly after patent expiry.
Patent Validity and Litigation
- Argentina employs ex-officio patent examination and opposition processes.
- Litigation in pharmaceutical patents remains infrequent but increasing, often related to patent extension or challenges to validity.
Specific Patent Landscape for AR036852
- The patent's filing or grant date influences its position in the patent lifecycle.
- If the patent was filed before 2013, it may be nearing expiry; later filings are currently in force.
- Similar patents are identified by patent databases (e.g., INPI Argentina, WIPO PATENTSCOPE), indicating a competitive environment if broader claims overlap.
Implications for Patent Owners and Competitors
- Broader claims create barrier to entry but risk invalidation if prior art is identified.
- Narrower claims may ease legitimacy but limit commercial scope.
- In regions with active patent challenges, enforceability varies based on patent quality and local courts' history.
Key Takeaways
- The scope of AR036852 primarily hinges on the breadth of its claims, which define protected chemical entities and formulations.
- The Argentine patent landscape favors strategic claim drafting to balance scope and validity.
- Patent clusters around certain therapeutic classes influence competitive positioning.
- Legal and policy frameworks support patent enforcement, but patent validity and overlaps are critical considerations.
- Early patent expiries or overlapping patents reduce commercial exclusivity for AR036852.
FAQs
1. What is the primary protection scope of AR036852?
It depends on the independent claims, which likely define specific chemical compounds or formulations. Narrower dependent claims specify particular embodiments.
2. Are there similar patents to AR036852 in Argentina?
Yes, patent searches identify similar filings, especially in related therapeutic areas or chemical scaffolds, creating potential overlap.
3. Can the claims be challenged or invalidated?
Yes, through opposition or invalidation procedures based on prior art or non-compliance with patentability criteria.
4. How does the patent landscape impact market entry?
A crowded patent landscape with overlapping filings can delay or complicate market entry for competitors.
5. When does AR036852 expire?
Based on its filing date, excluding dateline corrections or extensions, standard patent term applies—20 years from filing.
References
- Argentine Patent Law 24,481. (2000). National Institute of Industrial Property (INPI).
- World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
- Argentina Patent Database. (2023). INPI.
- World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
